help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faria, A. C.
Right arrow Articles by Vance, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faria, A. C.
Right arrow Articles by Vance, M. L.

Journal of Clinical Endocrinology & Metabolism, Vol 68, 535-541, Copyright © 1989 by Endocrine Society


ARTICLES

Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin

AC Faria, JD Veldhuis, MO Thorner and ML Vance
Department of Internal Medicine, University of Virginia Medical School, Charlottesville 22908.

The half-life (t1/2) of disappearance of endogenous GH from serum was studied using physiological effectors to stimulate and then suppress GH release. GH secretion was stimulated by a single iv injection of GHRH, followed 45 min later by an iv bolus dose and then a 2.5-h infusion of somatostatin (SRIH) to suppress further release. The in vivo t1/2 of GH in seven men was calculated from serum GH concentrations measured at frequent intervals after beginning the SRIH infusion. The mean t1/2 of endogenous GH was 18.9 +/- 0.8 (+/- SE) min by monoexponential analysis and 3.5 +/- 0.7 and 20.7 +/- 0.7 min by biexponential fitting. In these normal men, the decline in GH concentrations after GHRH and SRIH administration was similar to that after the administration of GHRH alone, which yielded a t1/2 of 20.3 +/- 1.9 min. We conclude that the physiological kinetics of endogenous GH removal/disappearance can be estimated in vivo in man using GHRH with or without SRIH infusion.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, G. A. Reynolds, A. Iranmanesh, and C. Y. Bowers
Twenty-Four Hour Continuous Ghrelin Infusion Augments Physiologically Pulsatile, Nycthemeral, and Entropic (Feedback-Regulated) Modes of Growth Hormone Secretion
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3597 - 3603.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. D. Veldhuis, D. M. Keenan, and C. Y. Bowers
Peripheral estrogen receptor-{alpha} selectively modulates the waveform of GH secretory bursts in healthy women
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1514 - R1521.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. D. Veldhuis, D. M. Keenan, and C. Y. Bowers
Estimation of the size and shape of GH secretory bursts in healthy women using a physiological estradiol clamp and variable-waveform deconvolution model
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1013 - R1021.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. Svensson, G. Johannsson, A. Iranmanesh, K. Albertsson-Wikland, J. D Veldhuis, and B.-A. Bengtsson
GH secretory pattern in young adults who discontinued GH treatment for GH deficiency and decreased longitudinal growth in childhood.
Eur. J. Endocrinol., July 1, 2006; 155(1): 91 - 99.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. D Veldhuis, J. M Patrie, K. Frick, J. Y Weltman, and A. L Weltman
Administration of recombinant human GHRH-1,44-amide for 3 months reduces abdominal visceral fat mass and increases physical performance measures in postmenopausal women
Eur. J. Endocrinol., November 1, 2005; 153(5): 669 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, D. Erickson, K. Mielke, L. S. Farhy, D. M. Keenan, and C. Y. Bowers
Distinctive Inhibitory Mechanisms of Age and Relative Visceral Adiposity on Growth Hormone Secretion in Pre- and Postmenopausal Women Studied under a Hypogonadal Clamp
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6006 - 6013.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. D Veldhuis, D. M Keenan, K. Mielke, J. M Miles, and C. Y Bowers
Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy
Eur. J. Endocrinol., October 1, 2005; 153(4): 577 - 586.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, A. Iranmanesh, and C. Y. Bowers
Joint Mechanisms of Impaired Growth-Hormone Pulse Renewal in Aging Men
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4177 - 4183.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, L. Farhy, A. L. Weltman, J. Kuipers, J. Weltman, and L. Wideman
Gender Modulates Sequential Suppression and Recovery of Pulsatile Growth Hormone Secretion by Physiological Feedback Signals in Young Adults
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2874 - 2881.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Soares-Welch, L. Farhy, K. L. Mielke, F. H. Mahmud, J. M. Miles, C. Y. Bowers, and J. D. Veldhuis
Complementary Secretagogue Pairs Unmask Prominent Gender-Related Contrasts in Mechanisms of Growth Hormone Pulse Renewal in Young Adults
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2225 - 2232.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, S. M. Anderson, A. Iranmanesh, and C. Y. Bowers
Testosterone Blunts Feedback Inhibition of Growth Hormone Secretion by Experimentally Elevated Insulin-Like Growth Factor-I Concentrations
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1613 - 1617.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. M. Buijs, P. W. de Leeuw, A. J. H. M. Houben, A. A. Kroon, M. Frolich, H. Pijl, and A. E. Meinders
Renal Contribution to Increased Clearance of Exogenous Growth Hormone in Obese Hypertensive Patients
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 795 - 799.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, J. Y. Weltman, A. L. Weltman, A. Iranmanesh, E. E. Muller, and C. Y. Bowers
Age and Secretagogue Type Jointly Determine Dynamic Growth Hormone Responses to Exogenous Insulin-Like Growth Factor-Negative Feedback in Healthy Men
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5542 - 5548.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Iranmanesh, C. Y. Bowers, and J. D. Veldhuis
Activation of Somatostatin-Receptor Subtype-2/-5 Suppresses the Mass, Frequency, and Irregularity of Growth Hormone (GH)-Releasing Peptide-2-Stimulated GH Secretion in Men
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4581 - 4587.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Erickson, D. M. Keenan, K. Mielke, K. Bradford, C. Y. Bowers, J. M. Miles, and J. D. Veldhuis
Dual Secretagogue Drive of Burst-Like Growth Hormone Secretion in Postmenopausal Compared with Premenopausal Women Studied under an Experimental Estradiol Clamp
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4746 - 4754.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Y. Bowers, R. Granda, S. Mohan, J. Kuipers, D. Baylink, and J. D. Veldhuis
Sustained Elevation of Pulsatile Growth Hormone (GH) Secretion and Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-3 (IGFBP-3), and IGFBP-5 Concentrations during 30-Day Continuous Subcutaneous Infusion of GH-Releasing Peptide-2 in Older Men and Women
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2290 - 2300.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, W. S. Evans, A. Iranmanesh, A. L. Weltman, and C. Y. Bowers
Short-Term Testosterone Supplementation Relieves Growth Hormone Autonegative Feedback in Men
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1285 - 1290.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, S. M. Anderson, P. Kok, A. Iranmanesh, J. Frystyk, H. Orskov, and D. M. Keenan
Estradiol Supplementation Modulates Growth Hormone (GH) Secretory-Burst Waveform and Recombinant Human Insulin-Like Growth Factor-I-Enforced Suppression of Endogenously Driven GH Release in Postmenopausal Women
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1312 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, J. Patrie, L. Wideman, M. Patterson, J. Y. Weltman, and A. Weltman
Contrasting Negative-Feedback Control of Endogenously Driven and Exercise-Stimulated Pulsatile Growth Hormone Secretion in Women and Men
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 840 - 846.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. B. Klerman, G. K. Adler, M. Jin, A. M. Maliszewski, and E. N. Brown
A statistical model of diurnal variation in human growth hormone
Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1118 - E1126.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Hussain, P. Hindmarsh, and A. Aynsley-Green
Spontaneous Hypoglycemia in Childhood Is Accompanied by Paradoxically Low Serum Growth Hormone and Appropriate Cortisol Counterregulatory Hormonal Responses
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3715 - 3723.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Svensson, J. D. Veldhuis, A. Iranmanesh, B.-A. Bengtsson, and G. Johannsson
Increased Orderliness of Growth Hormone (GH) Secretion in GH-Deficient Adults with Low Serum Insulin-Like Growth Factor I
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2863 - 2869.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. M. Anderson, L. Wideman, J. T. Patrie, A. Weltman, C. Y. Bowers, and J. D. Veldhuis
E2 Supplementation Selectively Relieves GH's Autonegative Feedback on GH-Releasing Peptide-2-Stimulated GH Secretion
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5904 - 5911.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. G. Langendonk, J. D. Veldhuis, J. Burggraaf, R. C. Schoemaker, A. F. Cohen, A. Edo Meinders, and H. Pijl
Estimation of growth hormone secretion rate: impact of kinetic assumptions intrinsic to the analytical approach
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R225 - R232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. G. Langendonk, A. E. Meinders, J. Burggraaf, M. Frolich, C. A. M. Roelen, R. C. Schoemaker, A. F. Cohen, and H. Pijl
Influence of obesity and body fat distribution on growth hormone kinetics in humans
Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E824 - E829.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. Kanaley, M. M. Weatherup-Dentes, E. B. Jaynes, and M. L. Hartman
Obesity Attenuates the Growth Hormone Response to Exercise
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3156 - 3161.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
G. M. Bright, J. D. Veldhuis, A. Iranmanesh, G. Baumann, H. Maheshwari, and J. Lima
Appraisal of Growth Hormone (GH) Secretion: Evaluation of a Composite Pharmacokinetic Model That Discriminates Multiple Components of GH Input
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3301 - 3308.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Shah, J. Aloi, W. S. Evans, and J. D. Veldhuis
Time Mode of Growth Hormone (GH) Entry into the Bloodstream and Steady-State Plasma GH Concentrations, Rather Than Sex, Estradiol, or Menstrual Cycle Stage, Primarily Determine the GH Elimination Rate in Healthy Young Women and Men
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2862 - 2869.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Mendlewicz, P. Linkowski, M. Kerkhofs, R. Leproult, G. Copinschi, and E. Van Cauter
Genetic Control of 24-Hour Growth Hormone Secretion in Man: A Twin Study
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 856 - 862.
[Abstract] [Full Text]


Home page
ScienceHome page
E Barr and J. Leiden
Systemic delivery of recombinant proteins by genetically modified myoblasts
Science, December 6, 1991; 254(5037): 1507 - 1509.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. G. Maheshwari, S. S. Pezzoli, A. Rahim, S. M. Shalet, M. O. Thorner, and G. Baumann
Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance
Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E943 - E951.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society